Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Strong association of de novo copy number mutations with sporadic schizophrenia

Abstract

Schizophrenia is an etiologically heterogeneous psychiatric disease, which exists in familial and nonfamilial (sporadic) forms1. Here, we examine the possibility that rare de novo copy number (CN) mutations with relatively high penetrance contribute to the genetic component of schizophrenia. We carried out a whole-genome scan and implemented a number of steps for finding and confirming CN mutations. Confirmed de novo mutations were significantly associated with schizophrenia (P = 0.00078) and were collectively 8 times more frequent in sporadic (but not familial) cases with schizophrenia than in unaffected controls. In comparison, rare inherited CN mutations were only modestly enriched in sporadic cases. Our results suggest that rare de novo germline mutations contribute to schizophrenia vulnerability in sporadic cases and that rare genetic lesions at many different loci can account, at least in part, for the genetic heterogeneity of this disease.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Procedures for CNV identification, de novo CNV detection and verification.
Figure 2: Identification and confirmation of a de novo CN mutation in a subject with schizophrenia.

References

  1. Gottesman, I.I. Schizophrenia Genesis. (W.H. Freeman and Company, New York, 1991).

    Google Scholar 

  2. Gottesman, I.I. & Shields, J. A polygenic theory of schizophrenia. Proc. Natl. Acad. Sci. USA 58, 199–205 (1967).

    Article  CAS  PubMed  Google Scholar 

  3. Sullivan, P.F., Kendler, K.S. & Neale, M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60, 1187–1192 (2003).

    Article  PubMed  Google Scholar 

  4. Pritchard, J.K. & Cox, N.J. The allelic architecture of human disease genes: common disease-common variant...or not? Hum. Mol. Genet. 11, 2417–2423 (2002).

    Article  CAS  PubMed  Google Scholar 

  5. Karayiorgou, M. & Gogos, J.A. Schizophrenia genetics: uncovering positional candidate genes. Eur. J. Hum. Genet. 14, 512–519 (2006).

    Article  CAS  PubMed  Google Scholar 

  6. Karayiorgou, M. et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. USA 92, 7612–7616 (1995).

    Article  CAS  PubMed  Google Scholar 

  7. Liu, H. et al. Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc. Natl. Acad. Sci. USA 99, 16859–16864 (2002).

    Article  CAS  PubMed  Google Scholar 

  8. MacIntyre, D.J., Blackwood, D.H., Porteous, D.J., Pickard, B.S. & Muir, W.J. Chromosomal abnormalities and mental illness. Mol. Psychiatry 8, 275–287 (2003).

    Article  CAS  PubMed  Google Scholar 

  9. Sebat, J. et al. Strong association of de novo copy number mutations with autism. Science 316, 445–449 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Marshall, C.R. et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82, 477–488 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Abecasis, G.R. et al. Genomewide scan in families with schizophrenia from the founder population of Afrikaners reveals evidence for linkage and uniparental disomy on chromosome 1. Am. J. Hum. Genet. 74, 403–417 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Autism Genome Project Consortium. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 39, 319–328 (2007).

  13. Li, C. & Wong, W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA 98, 31–36 (2001).

    Article  CAS  PubMed  Google Scholar 

  14. Redon, R. et al. Global variation in copy number in the human genome. Nature 444, 444–454 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Wiehahn, G.J. et al. Assessment of the frequency of the 22q11 deletion in Afrikaner schizophrenic patients. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 129, 20–22 (2004).

    Article  Google Scholar 

  16. Bennett, R.L., Karayiorgou, M., Sobin, C.A., Norwood, T.H. & Kay, M.A. Identification of an interstitial deletion in an adult female with schizophrenia, mental retardation, and dysmorphic features: further support for a putative schizophrenia-susceptibility locus at 5q21–23.1. Am. J. Hum. Genet. 61, 1450–1454 (1997).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lewis, C.M. et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am. J. Hum. Genet. 73, 34–48 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Chen, X. et al. Haplotypes spanning SPEC2, PDZ-GEF2 and ACSL6 genes are associated with schizophrenia. Hum. Mol. Genet. 15, 3329–3342 (2006).

    Article  CAS  PubMed  Google Scholar 

  19. Kuiperij, H.B. et al. Characterisation of PDZ-GEFs, a family of guanine nucleotide exchange factors specific for Rap1 and Rap2. Biochim. Biophys. Acta 1593, 141–149 (2003).

    Article  CAS  PubMed  Google Scholar 

  20. Kayser, M.S., McClelland, A.C., Hughes, E.G. & Dalva, M.B. Intracellular and trans-synaptic regulation of glutamatergic synaptogenesis by EphB receptors. J. Neurosci. 26, 12152–12164 (2006).

    Article  CAS  PubMed  Google Scholar 

  21. Yue, Y. et al. Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2. J. Neurosci. 19, 2090–2101 (1999).

    Article  CAS  PubMed  Google Scholar 

  22. Lyons-Warren, A. et al. Evidence of association between bipolar disorder and Citron on chromosome 12q24. Mol. Psychiatry 10, 807–809 (2005).

    Article  CAS  PubMed  Google Scholar 

  23. Di Cunto, F. et al. Defective neurogenesis in citron kinase knockout mice by altered cytokinesis and massive apoptosis. Neuron 28, 115–127 (2000).

    Article  CAS  PubMed  Google Scholar 

  24. Furuyashiki, T. et al. Citron, a Rho-target, interacts with PSD-95/SAP-90 at glutamatergic synapses in the thalamus. J. Neurosci. 19, 109–118 (1999).

    Article  CAS  PubMed  Google Scholar 

  25. Murchison, E.P. & Hannon, G.J. miRNAs on the move: miRNA biogenesis and the RNAi machinery. Curr. Opin. Cell Biol. 16, 223–229 (2004).

    Article  CAS  PubMed  Google Scholar 

  26. Stark, K.L. et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751–760 (2008).

    Article  CAS  PubMed  Google Scholar 

  27. Lupski, J.R. Genomic rearrangements and sporadic disease. Nat. Genet. 39, S43–S47 (2007).

    Article  CAS  PubMed  Google Scholar 

  28. Murphy, K.C., Jones, L.A. & Owen, M.J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch. Gen. Psychiatry 56, 940–945 (1999).

    Article  CAS  PubMed  Google Scholar 

  29. Pulver, A.E. et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J. Nerv. Ment. Dis. 182, 476–478 (1994).

    Article  CAS  PubMed  Google Scholar 

  30. Walsh, T. et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320, 539–543 (2008).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all the families who participated in this research. We also thank H. Pretorius and nursing sisters R. van Wyk, C. Botha and H. van den Berg for their assistance with subject recruitment and diagnostic evaluations. We thank A. Abrams-Downey and Y. Sun for expert technical assistance and J. Merriam and R.L. Allikmets for their help. We also thank A. Hagerty, J. Mote and J. Hallock for sample processing support and B. Boone and P. Dexheimer for genotyping data generation and support. All microarray experiments were performed in the Vanderbilt Microarray Shared Resource, which is supported by the Vanderbilt Ingram Cancer Center (P30 CA68485), the Vanderbilt Digestive Disease Center (P30 DK58404) and the Vanderbilt Vision Center (P30 EY08126). This work was supported in part by National Institute of Mental Health (NIMH) grants MH061399 (to M.K.) and MH077235 (to J.A.G.) and the Lieber Center for Schizophrenia Research at Columbia University Medical Center.

Author information

Authors and Affiliations

Authors

Contributions

B.X. carried out the analysis; J.L.R. collected subjects and participated in the diagnostic evaluations; E.J.V.R. collected a subset of the control subjects; S.L. oversaw the genotyping; J.A.G. and M.K. designed the project and oversaw the analysis; M.K. directed the project; and B.X., J.A.G. and M.K. wrote the paper.

Corresponding authors

Correspondence to Joseph A Gogos or Maria Karayiorgou.

Supplementary information

Supplementary Text and Figures

Supplementary Methods and Supplementary Tables 1–5 (PDF 588 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Xu, B., Roos, J., Levy, S. et al. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 40, 880–885 (2008). https://doi.org/10.1038/ng.162

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.162

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing